日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Insulin receptor expression and its association with hyperinsulinemia in triple negative breast cancer.

胰岛素受体表达及其与三阴性乳腺癌高胰岛素血症的关系。

期刊:Journal of the Endocrine Society
影响因子:3.1
doi:10.1210/jendso/bvag041
Engel Alexis J, Samuel Krupa, Bass Ilana R, Lin Sylvia, Antoniou Irini Markella, Yagnik Radhi, Port Elisa, Feldman Sheldon M, Friedman Neil B, Boolbol Susan K, Killelea Brigid, Pilewskie Melissa, Choi Lydia, Galifi Christopher A, Wood Teresa L, Kase Nathan G, LeRoith Derek, Bickell Nina A, Gallagher Emily J
乳腺癌
肿瘤
Insulin Receptor
发表日期：2026
文献求助 收藏

A PROTAC degrader suppresses oncogenic functions of PTK6, inducing apoptosis of breast cancer cells.

PROTAC降解剂抑制PTK6的致癌功能，诱导乳腺癌细胞凋亡

期刊:Cell Chemical Biology
影响因子:7.2
doi:10.1016/j.chembiol.2024.10.008
Martinez Criseyda, Xiong Yan, Bartkowski Alison, Harada Ibuki, Ren Xiaoxiao, Byerly Jessica, Port Elisa, Jin Jian, Irie Hanna
细胞生物学
乳腺癌
Apoptosis
凋亡
发表日期：2025
文献求助 收藏

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

CALGB 40603（联盟）：三阴性乳腺癌新辅助化疗联合或不联合卡铂和贝伐珠单抗治疗后的长期疗效及基因组相关性研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01506
Shepherd, Jonathan H; Ballman, Karla; Polley, Mei-Yin C; Campbell, Jordan D; Fan, Cheng; Selitsky, Sara; Fernandez-Martinez, Aranzazu; Parker, Joel S; Hoadley, Katherine A; Hu, Zhiyuan; Li, Yan; Soloway, Matthew G; Spears, Patricia A; Singh, Baljit; Tolaney, Sara M; Somlo, George; Port, Elisa R; Ma, Cynthia; Kuzma, Charles; Mamounas, Eleftherios; Golshan, Mehra; Bellon, Jennifer R; Collyar, Deborah; Hahn, Olwen M; Hudis, Clifford A; Winer, Eric P; Partridge, Ann; Hyslop, Terry; Carey, Lisa A; Perou, Charles M; Sikov, William M
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Insulin resistance and racial disparities in breast cancer prognosis: a multi-center cohort study

胰岛素抵抗与乳腺癌预后中的种族差异：一项多中心队列研究

期刊:Endocrine-Related Cancer
影响因子:4.6
doi:10.1530/ERC-22-0106
Gallagher, Emily J; Greco, Giampaolo; Lin, Sylvia; Yagnik, Radhi; Feldman, Sheldon M; Port, Elisa; Friedman, Neil B; Boolbol, Susan K; Killelea, Brigid; Pilewskie, Melissa; Choi, Lydia; LeRoith, Derek; Bickell, Nina A
肿瘤
肿瘤免疫
乳腺癌
代谢
免疫/内分泌
发表日期：2022
文献求助 收藏

Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 490 cases at a single institution

既往癌症或非典型增生史是否能预测经核心活检诊断的纯导管内乳头状瘤的组织学升级？一项来自单一机构的490例病例研究

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.1481
Alberty-Oller, J Jaime; Reyes, Sylvia; Moshier, Erin; Ru, Meng; Weltz, Sarah; Santos, Antonio; Pisapati, Kereeti; Port, Elisa; Jaffer, Shabnam
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Insulin resistance contributes to racial disparities in breast cancer prognosis in US women

胰岛素抵抗是导致美国女性乳腺癌预后存在种族差异的原因之一。

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-020-01281-y
Gallagher, Emily J; Fei, Kezhen; Feldman, Sheldon M; Port, Elisa; Friedman, Neil B; Boolbol, Susan K; Killelea, Brigid; Pilewskie, Melissa; Choi, Lydia; King, Tari; Nayak, Anupma; Franco, Rebeca; Cruz, Daliz; Antoniou, Irini M; LeRoith, Derek; Bickell, Nina A
肿瘤
肿瘤免疫
乳腺癌
代谢
免疫/内分泌
发表日期：2020
文献求助 收藏

The effect of modifiable risk factors on breast cancer aggressiveness among black and white women

可改变的风险因素对黑人和白人女性乳腺癌侵袭性的影响

期刊:American Journal of Surgery
影响因子:2.7
doi:10.1016/j.amjsurg.2019.07.012
Killelea, Brigid K; Gallagher, Emily J; Feldman, Sheldon M; Port, Elisa; King, Tari; Boolbol, Susan K; Franco, Rebeca; Fei, Kezhen; Le Roith, Derek; Bickell, Nina A
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

新辅助治疗对 II-III 期 HER2 阳性乳腺癌保乳手术的适用性和频率的影响：CALGB 40601（Alliance）的手术结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-016-4006-6
Golshan, Mehra; Cirrincione, Constance T; Sikov, William M; Carey, Lisa A; Berry, Donald A; Overmoyer, Beth; Henry, Nora L; Somlo, George; Port, Elisa; Burstein, Harold J; Hudis, Clifford; Winer, Eric; Ollila, David W
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)

在 II 期至 III 期三阴性乳腺癌中，新辅助每周一次紫杉醇治疗后，加用卡铂和/或贝伐单抗，随后给予剂量密集型多柔比星和环磷酰胺，对病理完全缓解率的影响：CALGB 40603（联盟）

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2014.57.0572
Sikov, William M; Berry, Donald A; Perou, Charles M; Singh, Baljit; Cirrincione, Constance T; Tolaney, Sara M; Kuzma, Charles S; Pluard, Timothy J; Somlo, George; Port, Elisa R; Golshan, Mehra; Bellon, Jennifer R; Collyar, Deborah; Hahn, Olwen M; Carey, Lisa A; Hudis, Clifford A; Winer, Eric P
肿瘤
肿瘤免疫
乳腺癌
发表日期：2015
文献求助 收藏

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

氟伐他汀可降低高级别乳腺癌患者的细胞增殖并增加其细胞凋亡。

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-009-0507-x
Garwood, Elisabeth R; Kumar, Anjali S; Baehner, Frederick L; Moore, Dan H; Au, Alfred; Hylton, Nola; Flowers, Chris I; Garber, Judy; Lesnikoski, Beth-Ann; Hwang, E Shelley; Olopade, Olofunmilao; Port, Elisa Rush; Campbell, Michael; Esserman, Laura J
肿瘤
凋亡
表观遗传
肿瘤免疫
乳腺癌
细胞生物学
发表日期：2010
文献求助 收藏